title: Altered redox status of coenzyme Q9 reflects mitochondrial electron transport chain deficiencies in Caenorhabditis elegans.
abstract: Mitochondrial disorders are often associated with primary or secondary CoQ10 decrease. In clinical practice, Coenzyme Q10 (CoQ10) levels are measured to diagnose deficiencies and to direct and monitor supplemental therapy. CoQ10 is reduced by complex I or II and oxidized by complex III in the mitochondrial respiratory chain. Therefore, the ratio between the reduced (ubiquinol) and oxidized (ubiquinone) CoQ10 may provide clinically significant information in patients with mitochondrial electron transport chain (ETC) defects. Here, we exploit mutants of Caenorhabditis elegans (C. elegans) with defined defects of the ETC to demonstrate an altered redox ratio in Coenzyme Q9 (CoQ9), the native quinone in these organisms. The percentage of reduced CoQ9 is decreased in complex I (gas-1) and complex II (mev-1) deficient animals, consistent with the diminished activity of these complexes that normally reduce CoQ9. As anticipated, reduced CoQ9 is increased in the complex III deficient mutant (isp-1), since the oxidase activity of the complex is severely defective. These data provide proof of principle of our hypothesis that an altered redox status of CoQ may be present in respiratory complex deficiencies. The assessment of CoQ10 redox status in patients with mitochondrial disorders may be a simple and useful tool to uncover and monitor specific respiratory complex defects.
authors.affiliation: Seattle Children's Research Institute, Seattle, WA, United States.
authors.forename: V
authors.initials: V
authors.lastname: Vasta
authors.forename: M
authors.initials: M
authors.lastname: Sedensky
authors.forename: P
authors.initials: P
authors.lastname: Morgan
authors.forename: S H
authors.initials: SH
authors.lastname: Hahn
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000378:metabolism*; D017173:Caenorhabditis elegans / Q000235:genetics / Q000378:metabolism*; D004195:Disease Models, Animal; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D008928:Mitochondria / Q000201:enzymology; D028361:Mitochondrial Diseases / Q000378:metabolism / Q000503:physiopathology*; D010084:Oxidation-Reduction; D014451:Ubiquinone / Q000031:analogs & derivatives / Q000378:metabolism*
chemical_list: D000975:Antioxidants; D014451:Ubiquinone; C003741:ubiquinol; C030571:ubiquinone 9